Related Experiment Videos

[Farquhar disease. Reduced phagocyte function in a 9-year-old girl with erythrophagocytic lymphohistiocytosis]

H Schroten1, A Kampmann, M Sperzel

  • 1Zentrum für Kinderheilkunde, Heinrich-Heine-Universität Düsseldorf.

Insights

Phagocyte function tests revealed impaired chemiluminescence and yeast-killing capacity in monocytes and granulocytes of an infant with familial hemophagocytic lymphohistiocytosis (HLH). These deficits persisted regardless of disease status, indicating a fundamental immune cell defect in HLH.

Area of Science:

  • Immunology
  • Cell Biology
  • Pediatric Hematology

Background:

  • Familial hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome.
  • Defective cytotoxic lymphocyte function is a hallmark of primary HLH, but phagocyte function in this condition requires further elucidation.
  • Understanding immune cell defects is crucial for diagnosing and managing HLH.

Observation:

  • Phagocyte function, specifically chemiluminescence and killing of Saccharomyces cerevisiae, was assessed in a female infant diagnosed with familial HLH.
  • Tests were conducted before and after chemotherapy, during remission, to evaluate functional capacity of monocytes and granulocytes.
  • The study focused on innate immune cell responses in the context of a primary immunodeficiency.

Findings:

  • Monocytes and granulocytes from the infant consistently demonstrated markedly reduced chemiluminescence.
  • The capacity of these phagocytes to kill Saccharomyces cerevisiae was also significantly impaired.
  • These functional deficits were observed irrespective of the infant's clinical stage, including remission post-chemotherapy.

Implications:

  • The findings suggest a potential intrinsic defect in phagocyte function in familial HLH, beyond the known cytotoxic T-cell abnormalities.
  • This could contribute to the overall immune dysregulation and hyperinflammation characteristic of HLH.
  • Further research into phagocyte dysfunction in HLH may reveal novel therapeutic targets and diagnostic markers.

Related Concept Videos